|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
47,934,000 |
Market
Cap: |
2.09(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.56 - $49.79 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Homology Medicines is a genetic medicines company. Co.'s proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors to deliver single administration genetic medicines in vivo either through its gene therapy, Co.'s nuclease-free gene editing modality, or Co.'s gene therapy to express antibodies platform. Co.'s clinical programs include: HMI-102, an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria; as well as HMI-103, an investigational gene editing candidate in clinical development for the treatment of patients with PKU.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
608 |
22,633 |
60,507 |
Total Sell Value |
$0 |
$14,716 |
$27,256 |
$80,181 |
Total People Sold |
0 |
3 |
3 |
7 |
Total Sell Transactions |
0 |
3 |
6 |
15 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Parmar Kush |
Director |
|
2019-05-16 |
4 |
S |
$21.47 |
$13,204,050 |
I/I |
(615,000) |
221,435 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
*Director by Deputization |
|
2019-04-12 |
4 |
B |
$22.50 |
$11,999,993 |
I/I |
533,333 |
1,158,333 |
2.25 |
- |
|
Parmar Kush |
Director |
|
2018-12-10 |
4 |
S |
$26.01 |
$405,029 |
I/I |
(15,575) |
246,035 |
|
- |
|
5am Co-Investors Iv, L.p. |
10% Owner |
|
2018-12-10 |
4 |
S |
$26.01 |
$405,029 |
I/I |
(15,575) |
246,035 |
|
- |
|
Parmar Kush |
Director |
|
2018-11-23 |
4 |
S |
$20.04 |
$594,709 |
I/I |
(29,682) |
246,658 |
|
- |
|
5am Co-Investors Iv, L.p. |
10% Owner |
|
2018-11-23 |
4 |
S |
$20.04 |
$594,709 |
I/I |
(29,682) |
246,658 |
|
- |
|
5am Co-Investors Iv, L.p. |
10% Owner |
|
2018-11-16 |
4 |
S |
$20.20 |
$10,623,180 |
I/I |
(525,900) |
247,845 |
|
- |
|
Parmar Kush |
Director |
|
2018-11-16 |
4 |
S |
$20.20 |
$10,623,180 |
I/I |
(525,900) |
247,845 |
|
- |
|
Shah Mahendra |
Director |
|
2018-04-02 |
4/A |
A |
$16.00 |
$4,000,000 |
I/I |
250,000 |
909,742 |
|
- |
|
Shah Mahendra |
Director |
|
2018-04-02 |
4 |
A |
$16.00 |
$8,000,000 |
I/I |
500,000 |
1,159,742 |
|
- |
|
Shah Mahendra |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
659,742 |
659,742 |
|
- |
|
Rock Springs Capital Llc |
10% Owner |
|
2018-04-02 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
645,845 |
1.5 |
- |
|
Rock Springs Capital Llc |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
395,845 |
395,845 |
|
- |
|
Nelsen Robert |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
6,068,695 |
6,068,695 |
|
- |
|
Parmar Kush |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
5,392,037 |
6,722,076 |
|
- |
|
Gillis Steven |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
6,068,695 |
6,068,695 |
|
- |
|
Parmar Kush |
Director |
|
2018-04-02 |
4/A |
A |
$0.00 |
$0 |
I/I |
5,392,037 |
6,722,076 |
|
- |
|
Vv Manager Llc |
10% Owner |
|
2018-04-02 |
4 |
B |
$16.00 |
$6,000,000 |
I/I |
375,000 |
770,845 |
1.5 |
- |
|
Vv Manager Llc |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
395,845 |
395,845 |
|
- |
|
Novartis Ag |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,979,226 |
1,979,226 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
*Director by Deputization |
|
2018-04-02 |
4 |
B |
$16.00 |
$20,000,000 |
I/I |
1,250,000 |
625,000 |
2.25 |
- |
|
Deerfield Mgmt Hif, L.p. |
*Director by Deputization |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,977,035 |
1,988,517 |
|
- |
|
5am Co-Investors Iv, L.p. |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
5,392,037 |
6,722,076 |
|
- |
|
V-Sciences Investments Pte Ltd |
10% Owner |
|
2018-04-02 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
3,220,293 |
1.5 |
- |
|
V-Sciences Investments Pte Ltd |
10% Owner |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,595,293 |
2,595,293 |
|
- |
|
150 Records found
|
|
Page 6 of 6 |
|
|